CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Oral ibandronate (150mg) administered monthly provides similar improvements in hip bone mineral density as oral alendronate (70mg) administered weekly in postmenopausal osteoporosis
Authors
Joao LC Borges
Felicia Cosman
+4 more
Colin Neate
Chris Recknor
Jean-Yves Reginster
Farhad Sedarati
Publication date
1 September 2007
Publisher
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Open Repository and Bibliography - Liège
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:orbi.ulg.ac.be:2268/82536
Last time updated on 20/08/2013